Syneron Bio Collaborates with AstraZeneca to Develop Macrocyclic Peptides for Chronic Diseases
CompanyDeals

Syneron Bio Collaborates with AstraZeneca to Develop Macrocyclic Peptides for Chronic Diseases

Hainan Poly Pharm Faces Delisting After CSRC Imposes Strict Penalties for Financial Misconduct
CompanyLegal / IP

Hainan Poly Pharm Faces Delisting After CSRC Imposes Strict Penalties for Financial Misconduct

AstraZeneca Unveils USD2.5 Billion Beijing R&D Center Plan Amid Strategic China Partnerships
CompanyDeals

AstraZeneca Unveils USD2.5 Billion Beijing R&D Center Plan Amid Strategic China Partnerships

Innovent Biologics Doses First Patient with IBI354 in HeriCare-Ovarian01 Study
CompanyDrug

Innovent Biologics Doses First Patient with IBI354 in HeriCare-Ovarian01 Study

Everest Medicines' EVM14 mRNA Cancer Vaccine Clears US FDA IND Application
CompanyDrug

Everest Medicines’ EVM14 mRNA Cancer Vaccine Clears US FDA IND Application

Harbour BioMed Partners with AstraZeneca on Multi-Specific Antibody Development
CompanyDeals

Harbour BioMed Partners with AstraZeneca on Multi-Specific Antibody Development

CSPC Pharmaceutical Group Gains NMPA Approval for SYS6040 Clinical Trial
CompanyDrug

CSPC Pharmaceutical Group Gains NMPA Approval for SYS6040 Clinical Trial

Duality Biotherapeutics Clears HKEX Hearing, Set for IPO with $2.7B Valuation
Company

Duality Biotherapeutics Clears HKEX Hearing, Set for IPO with $2.7B Valuation

China Biopharmaceutical Leads AI Integration with DeepSeek-R1
Company

China Biopharmaceutical Leads AI Integration with DeepSeek-R1

Driving Innovation in Traditional Chinese Medicine: A Policy-Backed Renaissance
Policy / Regulatory

Driving Innovation in Traditional Chinese Medicine: A Policy-Backed Renaissance

GE Healthcare Unveils Invenia ABUS Premium for Enhanced Dense Breast Screening
CompanyMedical Device

GE Healthcare Unveils Invenia ABUS Premium for Enhanced Dense Breast Screening

Daiichi Sankyo Launches Datroway in Japan for HR Positive, HER2 Negative Breast Cancer
CompanyDrug

Daiichi Sankyo Launches Datroway in Japan for HR Positive, HER2 Negative Breast Cancer